Profound Medical Corp.
PROF
Rank in Stocks
#15355
Profound Medical Corp., along with its subsidiaries, operates as a... Profound Medical Corp., along with its subsidiaries, operates as a commercial-stage medical technology firm. The company specializes in creating magnetic resonance (MR) guided ablation therapies designed to address prostate conditions, uterine fibroids, and to provide palliative pain management. Its market reach extends to Canada, Germany, the United States, and Finland. The company's primary offering is the TULSA-PRO system, which is engineered to integrate with magnetic resonance imaging (MRI) scanners within hospitals and clinical treatment facilities. Additionally, Profound Medical offers Sonalleve, a versatile therapeutic platform that treats uterine fibroids, delivers palliative pain relief for bone metastases, and provides non-invasive solutions for uterine fibroid treatment. Profound Medical Corp. maintains its corporate headquarters in Mississauga, Canada.
Share Price
$7.34
Last synced: 2026-11-09
Market Cap
$267.24M
Change (1 day)
1.80%
Change (1 year)
14.15%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Profound Medical Corp. (PROF)
Category
Healthcare
EPS for Profound Medical Corp. (PROF)
EPS as of September 2026 TTM: $-0.51
According to Profound Medical Corp.'s latest financial reports, its current EPS (TTM) is $-0.51. At the end of 2025 the company had an EPS of $-1.43, a decrease compared to its 2024 EPS of $-1.07.
EPS history for Profound Medical Corp. from 2012 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.51 | -64.34% |
| 2025 | $-1.43 | 33.64% |
| 2024 | $-1.07 | -20.74% |
| 2023 | $-1.35 | -2.17% |
| 2022 | $-1.38 | -8.00% |
| 2021 | $-1.50 | 20.00% |
| 2020 | $-1.25 | 16.94% |
| 2019 | $-1.07 | -4.61% |
| 2018 | $-1.12 | -42.25% |
| 2017 | $-1.94 | -33.71% |
| 2016 | $-2.93 | -41.25% |
| 2015 | $-4.98 | -84.71% |
| 2014 | $-32.58 | -47.19% |
| 2013 | $-61.69 | 45.46% |
| 2012 | $-42.41 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $2.70 | -629.41% |
US
|
|
| $4.09 | -901.96% |
IE
|
|
| $9.45 | -1,952.94% |
US
|
|
| $2.37 | -564.71% |
US
|
|
| $1.77 | -447.06% |
US
|
Questions about Profound Medical Corp.'s earnings per share (EPS)
What is Profound Medical Corp.'s earnings per share (EPS)?
Profound Medical Corp.'s earnings per share (EPS) over the last twelve months is $-0.51, as of Sep 2026.
What was Profound Medical Corp.'s earnings per share (EPS) in 2025?
In 2025, Profound Medical Corp.'s earnings per share (EPS) was $-1.43, compared with $-1.07 in 2024.
How has Profound Medical Corp.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Profound Medical Corp.'s earnings per share (EPS) was highest in 2024 ($-1.07) and lowest in 2021 ($-1.50).
How does Profound Medical Corp.'s earnings per share (EPS) compare with similar companies?
Profound Medical Corp.'s earnings per share (EPS) ($-0.51) is lower than that of all 5 similar companies listed above. The highest among them is Stryker Corporation, with $9.45.